These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1138024)

  • 21. Determinants of fecal and urinary iron excretion in desferrioxamine-treated rats.
    Hershko C
    Blood; 1978 Mar; 51(3):415-23. PubMed ID: 623907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-phthaloyl-glycine-hydroxamic acid as serum iron chelator in rats.
    Matijević-Sosa J; Samarzija I; Honović L; Jurisić B
    Acta Pharm; 2008 Jun; 58(2):231-6. PubMed ID: 18515233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron overload syndromes.
    Pollycove M
    Clin Physiol Biochem; 1986; 4(1):61-77. PubMed ID: 3956074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the microsomal oxidation of ethanol and 1-butanol by the free-radical, spin-trapping agent 5,5-dimethyl-1-pyrroline-1-oxide.
    Cederabum AI; Cohen G
    Arch Biochem Biophys; 1980 Oct; 204(2):397-403. PubMed ID: 6778392
    [No Abstract]   [Full Text] [Related]  

  • 25. Storage iron kinetics. 3. Study of desferrioxamine action by selective radioiron labels of RE and parenchymal cells.
    Hershko C; Cook JD; Finch DA
    J Lab Clin Med; 1973 Jun; 81(6):876-86. PubMed ID: 4196982
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of iron-chelating agents in cultured heart muscle cells. Identification of a potential drug for chelation therapy.
    Sciortino CV; Byers BR; Cox P
    J Lab Clin Med; 1980 Dec; 96(6):1081-5. PubMed ID: 7430764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of desferrioxamine, a strong iron (III) chelator, on 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in the rat striatum.
    Obata T
    Eur J Pharmacol; 2006 Jun; 539(1-2):34-8. PubMed ID: 16650845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of orally administered chelating agents EDTA, DTPA and fructose on radioiron absorption in man.
    Davis PS; Deller DJ
    Australas Ann Med; 1967 Feb; 16(1):70-4. PubMed ID: 4962004
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on the question of enteral resorption of irn].
    Nigrović V; Spreng P; Bohne F
    Nucl Med (Stuttg); 1967; ():147-50. PubMed ID: 5601729
    [No Abstract]   [Full Text] [Related]  

  • 30. IRC011, a new synthetic chelator with selective interaction with catabolic red blood cell iron: evaluation in hypertransfused rats with hepatocellular and reticuloendothelial radioiron probes and in iron-loaded rat heart cells in culture.
    Rivkin G; Link G; Simhon E; Cyjon RL; Klein JY; Hershko C
    Blood; 1997 Nov; 90(10):4180-7. PubMed ID: 9354689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal salvage of haemoglobin iron.
    Pshetisky D; Hershko C
    Scand J Haematol; 1977 Aug; 19(2):192-200. PubMed ID: 897559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of chelating agents on the distribution of 210 Po in rats.
    Volf V
    Experientia; 1973 Mar; 29(3):307-8. PubMed ID: 4708709
    [No Abstract]   [Full Text] [Related]  

  • 33. Liver iron: changes induced by cooking and acid-peptic digestion.
    Naish R; Kimber CL; Deller DJ
    Br J Haematol; 1974 Mar; 26(3):459-68. PubMed ID: 4212143
    [No Abstract]   [Full Text] [Related]  

  • 34. Phenolic ethylenediamine derivatives: a study of orally effective iron chelators.
    Hershko C; Grady RW; Link G
    J Lab Clin Med; 1984 Mar; 103(3):337-46. PubMed ID: 6699459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of DNA synthesis in CCL 39 cells by impermeable iron chelators.
    Alcaín FJ; Löw H; Crane FL
    Biochem Mol Biol Int; 1997 Feb; 41(2):303-10. PubMed ID: 9063570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of prolonged fasting on iron stores and blood constituents in young swine.
    Furugouri K
    J Anim Sci; 1973 Sep; 37(3):697-700. PubMed ID: 4742099
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of chang cells cultured in vitro to evaluate potential iron chelating drugs.
    White GP; Jacobs A; Grady RW; Cerami A
    Br J Haematol; 1976 Aug; 33(4):487-95. PubMed ID: 1009021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plutonium uptake by cell cultures in presence of some chelating agents.
    Popplewell DS
    Health Phys; 1973 Oct; 25(4):413-20. PubMed ID: 4785418
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical trial of 5-hydroxypicolinaldehyde thiosemicarbazone (5-HP; NSC-107392), with special reference to its iron-chelating properties.
    Krakoff IH; Etcubanas E; Tan C; Mayer K; Bethune V; Burchenal JH
    Cancer Chemother Rep; 1974; 58(2):207-12. PubMed ID: 4598241
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of ferritin with liver cell membrane fractions.
    Sargent KS; Munro HN
    Exp Cell Res; 1975 Jun; 93(1):15-22. PubMed ID: 1140216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.